PRASTERONE

PRASTERONE was reported 2752 times

PRASTERONE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SELECTIVE IGM IMMUNODEFICIENCY 2 0.2500
1 COXSACKIE VIRUS TEST POSITIVE 3 0.1429
2 GONADOTROPHIN DEFICIENCY 3 0.1111
3 APPLICATION SITE DISCHARGE 115 0.0997
4 ADMINISTRATION SITE DISCHARGE 5 0.0862
5 DEHYDROEPIANDROSTERONE INCREASED 3 0.0435
6 TENDON CALCIFICATION 6 0.0339
7 BLOOD TESTOSTERONE FREE INCREASED 2 0.0333
8 BUTTERFLY RASH 24 0.0237
9 OESTRADIOL INCREASED 6 0.0199
10 ABORTION EARLY 2 0.0185
11 PROGESTERONE INCREASED 2 0.0180
12 INSULIN-LIKE GROWTH FACTOR ABNORMAL 2 0.0177
13 ABDOMINAL FAT APRON 2 0.0171
14 VULVOVAGINAL INFLAMMATION 7 0.0152
15 CERVIX INFLAMMATION 2 0.0147
16 VULVOVAGINAL ERYTHEMA 12 0.0144
17 PRODUCT PACKAGING DIFFICULT TO OPEN 36 0.0138
18 CONTRAINDICATED PRODUCT PRESCRIBED 23 0.0137
19 VULVOVAGINAL BURNING SENSATION 80 0.0131
20 B-CELL SMALL LYMPHOCYTIC LYMPHOMA 3 0.0130
21 CD4 LYMPHOCYTES INCREASED 3 0.0129
22 BLOOD ZINC DECREASED 2 0.0110
23 SPINAL CORD ABSCESS 3 0.0110
24 CRYPTOGENIC ORGANIZING PNEUMONIA 2 0.0104
25 VULVOVAGINAL DISCOMFORT 46 0.0104
26 PROGESTERONE DECREASED 3 0.0096
27 VULVOVAGINAL RASH 4 0.0091
28 AORTIC THROMBOSIS 10 0.0087
29 GASTROINTESTINAL MICROORGANISM OVERGROWTH 3 0.0085
30 VAGINAL DISCHARGE 85 0.0084
31 INSULIN-LIKE GROWTH FACTOR DECREASED 4 0.0076
32 BLOOD CORTICOTROPHIN INCREASED 2 0.0069
33 URETHRAL PAIN 4 0.0068
34 URINARY TRACT DISCOMFORT 3 0.0065
35 BREAST INFLAMMATION 2 0.0065
36 SKIN OPERATION 2 0.0064
37 VAGINAL ODOUR 8 0.0064
38 VULVOVAGINAL PRURITUS 32 0.0063
39 OESTRADIOL DECREASED 2 0.0062
40 PERIPHERAL NERVE LESION 2 0.0061
41 STIFF PERSON SYNDROME 2 0.0058
42 BLOOD OESTROGEN DECREASED 4 0.0057
43 VULVOVAGINAL PAIN 27 0.0056
44 BODY FAT DISORDER 3 0.0055
45 GESTATIONAL HYPERTENSION 7 0.0054
46 ENDOMETRIAL THICKENING 3 0.0054
47 NASAL TURBINATE HYPERTROPHY 2 0.0053
48 VULVOVAGINAL INJURY 3 0.0053
49 BLOOD OESTROGEN INCREASED 3 0.0051
50 ADENOMYOSIS 3 0.0051
51 GROWTH HORMONE DEFICIENCY 2 0.0050
52 PRODUCT PACKAGE ASSOCIATED INJURY 11 0.0049
53 HIGH FREQUENCY ABLATION 2 0.0049
54 CRANIOFACIAL FRACTURE 4 0.0047
55 PERIORBITAL OEDEMA 24 0.0046
56 REFLUX LARYNGITIS 2 0.0045
57 INFUSION SITE SCAR 2 0.0045
58 PROCEDURAL ANXIETY 3 0.0044
59 POOR QUALITY PRODUCT ADMINISTERED 45 0.0043
60 GRANULOMATOUS LIVER DISEASE 3 0.0043
61 PELVIC DISCOMFORT 4 0.0042
62 EMBOLISM ARTERIAL 5 0.0042
63 ATROPHIC VULVOVAGINITIS 3 0.0041
64 RESPIRATORY TRACT INFECTION BACTERIAL 2 0.0040
65 EXPOSURE VIA PARTNER 2 0.0040
66 EXTRADURAL ABSCESS 3 0.0038
67 SMEAR CERVIX ABNORMAL 5 0.0035
68 NAIL INJURY 2 0.0035
69 CORTISOL DECREASED 4 0.0035
70 ADMINISTRATION SITE PAIN 4 0.0035
71 VULVOVAGINAL DRYNESS 11 0.0034
72 ELBOW OPERATION 2 0.0032
73 BACTERIAL VAGINOSIS 5 0.0032
74 PRODUCT PACKAGING ISSUE 30 0.0032
75 ENDOMETRIAL ADENOCARCINOMA 2 0.0031
76 VAGINAL DISORDER 3 0.0031
77 PRODUCT ADMINISTRATION ERROR 62 0.0031
78 LIBIDO INCREASED 6 0.0030
79 DISCHARGE 4 0.0029
80 OPHTHALMIC MIGRAINE 2 0.0029
81 MAST CELL ACTIVATION SYNDROME 4 0.0028
82 APPLICATION SITE DISCOMFORT 5 0.0028
83 INFUSION SITE MASS 3 0.0028
84 VULVOVAGINAL SWELLING 5 0.0027
85 CYCLIC VOMITING SYNDROME 2 0.0027
86 SMALL FIBRE NEUROPATHY 2 0.0027
87 ESSENTIAL TREMOR 3 0.0027
88 GINGIVAL ABSCESS 2 0.0027
89 PRODUCT PHYSICAL ISSUE 53 0.0026
90 POST-ACUTE COVID-19 SYNDROME 3 0.0024
91 GASTRIC INFECTION 9 0.0024
92 MYCOTIC ALLERGY 2 0.0023
93 INFUSION SITE DISCOLOURATION 2 0.0023
94 BREAST TENDERNESS 17 0.0023
95 BREAST SWELLING 6 0.0022
96 NEUROMYELITIS OPTICA SPECTRUM DISORDER 3 0.0022
97 INFUSION SITE RASH 3 0.0022
98 UTERINE SPASM 4 0.0022
99 BLOOD UREA ABNORMAL 2 0.0021
100 LYME DISEASE 7 0.0021
101 BLOOD PARATHYROID HORMONE INCREASED 6 0.0021
102 CYTOMEGALOVIRUS CHORIORETINITIS 4 0.0020
103 BENIGN BREAST NEOPLASM 2 0.0020
104 PLEURAL FIBROSIS 2 0.0020
105 PRODUCT BLISTER PACKAGING ISSUE 2 0.0019
106 PRODUCT ADMINISTRATION INTERRUPTED 15 0.0019
107 SINUSITIS BACTERIAL 2 0.0019
108 BLADDER PAIN 6 0.0019
109 HAIR GROWTH ABNORMAL 13 0.0019
110 BLOOD TESTOSTERONE INCREASED 4 0.0019
111 INFUSION SITE BRUISING 4 0.0019
112 CERVICAL DYSPLASIA 4 0.0018
113 CEREBELLAR INFARCTION 3 0.0018
114 BENIGN NEOPLASM 2 0.0018
115 MACROCYTOSIS 2 0.0017
116 CARDIAC DEATH 2 0.0017
117 LOSS OF EMPLOYMENT 5 0.0017
118 CEREBRAL VENOUS THROMBOSIS 3 0.0017
119 SUSPECTED PRODUCT QUALITY ISSUE 3 0.0016
120 HEAD DISCOMFORT 29 0.0016
121 BLADDER PROLAPSE 2 0.0016
122 HAEMATOLOGICAL INFECTION 4 0.0016
123 PHOTOSENSITIVITY REACTION 27 0.0016
124 ALLERGY TO CHEMICALS 2 0.0016
125 AORTIC VALVE REPLACEMENT 2 0.0016
126 HYPERAESTHESIA TEETH 2 0.0016
127 HYPERCOAGULATION 3 0.0016
128 LIPOMA 4 0.0015
129 LYMPHOCYTE COUNT INCREASED 5 0.0015
130 LIP INJURY 2 0.0015
131 AFFECTIVE DISORDER 12 0.0015
132 VULVOVAGINAL MYCOTIC INFECTION 6 0.0015
133 DIPLEGIA 3 0.0015
134 MICTURITION URGENCY 17 0.0015
135 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 2 0.0015
136 IMMUNOGLOBULINS DECREASED 2 0.0015
137 CHEST INJURY 3 0.0014
138 TRICHORRHEXIS 4 0.0014
139 LOW DENSITY LIPOPROTEIN DECREASED 2 0.0014
140 INCORRECT DRUG ADMINISTRATION RATE 6 0.0014
141 SKIN WEEPING 5 0.0014
142 LYMPHOCYTOSIS 3 0.0014
143 OBSTRUCTIVE SLEEP APNOEA SYNDROME 2 0.0014
144 WALKING AID USER 9 0.0014
145 THERAPEUTIC RESPONSE UNEXPECTED 61 0.0014
146 COMPLEX REGIONAL PAIN SYNDROME 2 0.0014
147 HAEMATOCRIT INCREASED 3 0.0013
148 DYSPAREUNIA 6 0.0013
149 PNEUMONIA PSEUDOMONAL 2 0.0013
150 MENOPAUSAL SYMPTOMS 3 0.0013
151 SUBSTANCE USE 2 0.0013
152 ORAL SURGERY 3 0.0013
153 MULTIPLE ALLERGIES 10 0.0013
154 CYSTITIS INTERSTITIAL 2 0.0012
155 INTENTIONAL UNDERDOSE 9 0.0012
156 BLOOD PRESSURE SYSTOLIC ABNORMAL 3 0.0012
157 NEAR DEATH EXPERIENCE 4 0.0012
158 SPLEEN DISORDER 2 0.0012
159 INSURANCE ISSUE 18 0.0012
160 PRODUCT COLOUR ISSUE 6 0.0012
161 ARTERIOSCLEROSIS 11 0.0012
162 SPONDYLOLISTHESIS 2 0.0012
163 POSTMENOPAUSAL HAEMORRHAGE 3 0.0011
164 INFUSION SITE DISCHARGE 2 0.0011
165 DERMATITIS CONTACT 13 0.0011
166 PANCREATIC FAILURE 2 0.0011
167 BREAST CYST 2 0.0011
168 MACULOPATHY 4 0.0011
169 INFUSION SITE SWELLING 7 0.0011
170 VAGINAL HAEMORRHAGE 48 0.0011
171 BLADDER SPASM 2 0.0011
172 VAGINAL INFECTION 5 0.0011
173 SEASONAL ALLERGY 15 0.0011
174 AUTOIMMUNE THYROIDITIS 4 0.0011
175 JOINT LOCK 3 0.0011
176 ADRENAL DISORDER 2 0.0010
177 NASAL SEPTUM DEVIATION 2 0.0010
178 EXTRASYSTOLES 7 0.0010
179 EYELID PAIN 2 0.0010
180 POLYCYTHAEMIA 2 0.0010
181 SOCIAL PROBLEM 4 0.0010
182 PRE-EXISTING CONDITION IMPROVED 6 0.0010
183 INFUSION SITE PRURITUS 3 0.0009
184 EYE CONTUSION 2 0.0009
185 INFUSION SITE PAIN 12 0.0009
186 TENSION HEADACHE 4 0.0009
187 HORDEOLUM 4 0.0009
188 OFF LABEL USE 803 0.0009
189 BREAST ENLARGEMENT 3 0.0009
190 MIDDLE EAR EFFUSION 2 0.0009
191 BRAIN FOG 14 0.0009
192 TINNITUS 41 0.0009
193 CONTRAINDICATED PRODUCT ADMINISTERED 27 0.0009
194 PRODUCT USE COMPLAINT 14 0.0009
195 GASTROINTESTINAL HYPOMOTILITY 2 0.0009
196 HAEMOGLOBIN INCREASED 4 0.0009
197 ROSACEA 4 0.0009
198 SINUS PAIN 2 0.0009
199 HANGOVER 3 0.0009
200 UPPER-AIRWAY COUGH SYNDROME 7 0.0008
201 ENERGY INCREASED 5 0.0008
202 SKIN ABRASION 4 0.0008
203 BREAST PAIN 9 0.0008
204 FAECES SOFT 6 0.0008
205 SEBORRHOEA 3 0.0008
206 MENISCUS INJURY 5 0.0008
207 PROTEIN TOTAL DECREASED 3 0.0008
208 PRODUCT SOLUBILITY ABNORMAL 4 0.0008
209 ENDODONTIC PROCEDURE 2 0.0008
210 PARANASAL SINUS HYPERSECRETION 3 0.0008
211 FOREIGN BODY SENSATION IN EYES 5 0.0008
212 DRUG TITRATION ERROR 2 0.0008
213 POOR VENOUS ACCESS 8 0.0008
214 PELVIC PAIN 14 0.0008
215 RESTLESS LEGS SYNDROME 14 0.0008
216 POLYP 5 0.0008
217 TEMPOROMANDIBULAR JOINT SYNDROME 2 0.0007
218 INTRACRANIAL ANEURYSM 3 0.0007
219 MYCOBACTERIUM AVIUM COMPLEX INFECTION 2 0.0007
220 RHINITIS 6 0.0007
221 ENURESIS 3 0.0007
222 FRUSTRATION TOLERANCE DECREASED 6 0.0007
223 NOCTURIA 9 0.0007
224 CHONDROPATHY 2 0.0007
225 PRODUCT LABEL ISSUE 5 0.0007
226 ARTHRITIS BACTERIAL 3 0.0007
227 HYPERKERATOSIS 4 0.0007
228 TENOSYNOVITIS 2 0.0007
229 MACULE 2 0.0007
230 HOT FLUSH 54 0.0007
231 ATTENTION DEFICIT HYPERACTIVITY DISORDER 3 0.0007
232 MAJOR DEPRESSION 5 0.0007
233 SPINAL OSTEOARTHRITIS 6 0.0007
234 NIGHT SWEATS 22 0.0007
235 SLEEP APNOEA SYNDROME 13 0.0007
236 PHYSICAL DISABILITY 3 0.0007
237 SENSITIVE SKIN 5 0.0007
238 LOWER LIMB FRACTURE 13 0.0007
239 RHINITIS ALLERGIC 3 0.0007
240 SINUS HEADACHE 4 0.0007
241 INFUSION SITE REACTION 2 0.0007
242 SUSPECTED OFF LABEL USE 3 0.0007
243 BLOOD THYROID STIMULATING HORMONE DECREASED 3 0.0007
244 EYE INJURY 2 0.0007
245 UNDERDOSE 48 0.0007
246 DEAFNESS 17 0.0006
247 FIBROSIS 2 0.0006
248 TENDON RUPTURE 8 0.0006
249 SCOLIOSIS 4 0.0006
250 EPSTEIN-BARR VIRUS INFECTION 4 0.0006
251 SKIN TIGHTNESS 3 0.0006
252 CELLULITIS 32 0.0006
253 COLITIS MICROSCOPIC 3 0.0006
254 IRIDOCYCLITIS 2 0.0006
255 FUNGAL INFECTION 21 0.0006
256 GINGIVAL PAIN 5 0.0006
257 CARDIAC FLUTTER 4 0.0006
258 INCORRECT DOSAGE ADMINISTERED 3 0.0006
259 PHARYNGEAL SWELLING 6 0.0006
260 PANCREATIC DISORDER 3 0.0006
261 HYPOGAMMAGLOBULINAEMIA 4 0.0006
262 LISTLESS 2 0.0006
263 FEELING HOT 37 0.0006
264 SKIN INJURY 2 0.0006
265 BREAST MASS 4 0.0006
266 LEFT VENTRICULAR FAILURE 2 0.0006
267 DEPRESSION SUICIDAL 2 0.0006
268 GRANULOMA 2 0.0006
269 TACHYPHRENIA 2 0.0006
270 FEELING JITTERY 11 0.0006
271 MALABSORPTION 3 0.0006
272 MUSCLE CONTRACTIONS INVOLUNTARY 2 0.0006
273 NYSTAGMUS 3 0.0006
274 GINGIVITIS 3 0.0006
275 STRESS FRACTURE 3 0.0006
276 LOSS OF LIBIDO 5 0.0006
277 SINUS DISORDER 11 0.0006
278 SKIN LACERATION 6 0.0006
279 BACK INJURY 6 0.0006
280 POLLAKIURIA 23 0.0006
281 SCLERODERMA 2 0.0005
282 EXOSTOSIS 5 0.0005
283 BLOOD PHOSPHORUS DECREASED 2 0.0005
284 FOOD INTOLERANCE 2 0.0005
285 APPLICATION SITE PAIN 12 0.0005
286 INCREASED TENDENCY TO BRUISE 5 0.0005
287 ARTHROPOD BITE 4 0.0005
288 FEELING DRUNK 4 0.0005
289 SINUSITIS 55 0.0005
290 OCULAR DISCOMFORT 6 0.0005
291 CHRONIC SINUSITIS 2 0.0005
292 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 29 0.0005
293 EAR INFECTION 14 0.0005
294 SKIN ATROPHY 3 0.0005
295 FOOD ALLERGY 4 0.0005
296 LOW DENSITY LIPOPROTEIN INCREASED 4 0.0005
297 CONCUSSION 4 0.0005
298 SKIN WARM 3 0.0005
299 URINE ODOUR ABNORMAL 3 0.0005
300 SKIN ODOUR ABNORMAL 2 0.0005
301 LIGAMENT SPRAIN 5 0.0005
302 MACULAR DEGENERATION 6 0.0005
303 FUNGAL SKIN INFECTION 2 0.0005
304 SPINAL FUSION SURGERY 2 0.0005
305 SWELLING FACE 32 0.0005
306 DEMYELINATION 2 0.0005
307 INITIAL INSOMNIA 5 0.0005
308 EAR DISCOMFORT 5 0.0005
309 SELF-MEDICATION 2 0.0005
310 SPINAL STENOSIS 2 0.0005
311 FEMUR FRACTURE 15 0.0005
312 LIMB INJURY 13 0.0005
313 LIVE BIRTH 4 0.0005
314 WEIGHT FLUCTUATION 5 0.0005
315 HALLUCINATIONS, MIXED 2 0.0005
316 INFUSION SITE ERYTHEMA 4 0.0005
317 SKIN PLAQUE 4 0.0005
318 MUSCLE FATIGUE 2 0.0005
319 BUNDLE BRANCH BLOCK LEFT 2 0.0005
320 INJECTION SITE IRRITATION 6 0.0005
321 CYSTITIS 15 0.0005
322 INTERVERTEBRAL DISC DISORDER 2 0.0005
323 HAEMOGLOBIN ABNORMAL 3 0.0005
324 TEARFULNESS 2 0.0005
325 HYPOAESTHESIA ORAL 7 0.0005
326 HEART RATE INCREASED 46 0.0005
327 MUSCLE STRAIN 4 0.0005
328 TENDON DISORDER 3 0.0005
329 MELANOCYTIC NAEVUS 2 0.0005
330 DYSGRAPHIA 3 0.0005
331 TOOTH INFECTION 6 0.0005
332 THYROID DISORDER 7 0.0005
333 GINGIVAL SWELLING 2 0.0005
334 BLOOD PRESSURE ABNORMAL 9 0.0005
335 BLOOD CREATINE INCREASED 2 0.0005
336 RESPIRATORY RATE INCREASED 4 0.0005
337 FACIAL PAIN 4 0.0004
338 IMPLANT SITE PAIN 2 0.0004
339 ILLNESS 46 0.0004
340 SKIN INFECTION 5 0.0004
341 MENINGITIS ASEPTIC 2 0.0004
342 BRONCHIECTASIS 3 0.0004
343 IRON DEFICIENCY 2 0.0004
344 CHROMATURIA 10 0.0004
345 OROPHARYNGEAL DISCOMFORT 4 0.0004
346 PRODUCT DOSE OMISSION ISSUE 130 0.0004
347 IMPAIRED GASTRIC EMPTYING 6 0.0004
348 MIGRAINE 42 0.0004
349 BLOOD TESTOSTERONE DECREASED 3 0.0004
350 UROSEPSIS 4 0.0004
351 IRON DEFICIENCY ANAEMIA 4 0.0004
352 PERSONALITY CHANGE 4 0.0004
353 CARPAL TUNNEL SYNDROME 6 0.0004
354 APPENDICITIS 4 0.0004
355 DISCOMFORT 26 0.0004
356 SPUTUM DISCOLOURED 4 0.0004
357 PARAESTHESIA ORAL 6 0.0004
358 AFFECT LABILITY 4 0.0004
359 PANIC REACTION 3 0.0004
360 VISUAL FIELD DEFECT 3 0.0004
361 ALOPECIA 81 0.0004
362 ADRENAL INSUFFICIENCY 5 0.0004
363 NEURALGIA 10 0.0004
364 BLOOD PRESSURE SYSTOLIC INCREASED 8 0.0004
365 VITAMIN D DEFICIENCY 4 0.0004
366 HORMONE LEVEL ABNORMAL 2 0.0004
367 MOOD SWINGS 13 0.0004
368 DYSURIA 15 0.0004
369 HYPOTHYROIDISM 13 0.0004
370 SPINAL OPERATION 5 0.0004
371 STAPHYLOCOCCAL SEPSIS 2 0.0004
372 DISABILITY 8 0.0004
373 INABILITY TO AFFORD MEDICATION 4 0.0004
374 ANEURYSM 2 0.0004
375 BURNING SENSATION 28 0.0004
376 DERMATITIS ALLERGIC 5 0.0004
377 OSTEOPENIA 6 0.0004
378 DRUG TOLERANCE 2 0.0004
379 URINARY TRACT INFECTION 67 0.0004
380 THIRST 7 0.0004
381 DEVICE PHYSICAL PROPERTY ISSUE 3 0.0004
382 ROTATOR CUFF SYNDROME 5 0.0004
383 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 10 0.0004
384 BENIGN PROSTATIC HYPERPLASIA 2 0.0004
385 INTENTIONAL DOSE OMISSION 11 0.0004
386 ANKYLOSING SPONDYLITIS 5 0.0004
387 SERUM FERRITIN INCREASED 2 0.0004
388 PRODUCTIVE COUGH 18 0.0004
389 HYPOACUSIS 16 0.0004
390 POOR QUALITY SLEEP 8 0.0004
391 MYASTHENIA GRAVIS 3 0.0004
392 MUSCLE DISORDER 3 0.0004
393 SINUS CONGESTION 5 0.0004
394 FRACTURE 7 0.0004
395 PHARYNGITIS STREPTOCOCCAL 4 0.0004
396 ERYTHEMA OF EYELID 2 0.0004
397 LYMPHADENOPATHY 13 0.0004
398 HYPERAESTHESIA 3 0.0004
399 BRONCHITIS 27 0.0004
400 PERIPHERAL COLDNESS 5 0.0004
401 ASTHENOPIA 2 0.0004
402 INTESTINAL ISCHAEMIA 2 0.0004
403 DEAFNESS UNILATERAL 2 0.0004
404 CHOKING SENSATION 2 0.0004
405 BLOOD ALKALINE PHOSPHATASE INCREASED 9 0.0004
406 INJECTION SITE INJURY 2 0.0004
407 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 65 0.0004
408 FEELING COLD 10 0.0004
409 ORAL HERPES 7 0.0004
410 INTERMENSTRUAL BLEEDING 2 0.0004
411 SENSATION OF FOREIGN BODY 3 0.0004
412 BLOOD CALCIUM DECREASED 4 0.0004
413 PERIORBITAL SWELLING 2 0.0004
414 PRODUCT DOSE OMISSION 23 0.0004
415 GENERALISED ERYTHEMA 2 0.0004
416 PALPITATIONS 41 0.0003
417 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 6 0.0003
418 INSOMNIA 93 0.0003
419 HYPERSOMNIA 10 0.0003
420 BLOOD MAGNESIUM DECREASED 3 0.0003
421 HEAD INJURY 11 0.0003
422 SWELLING 32 0.0003
423 FEELING OF BODY TEMPERATURE CHANGE 2 0.0003
424 DRY EYE 17 0.0003
425 COLD SWEAT 6 0.0003
426 OSTEOPOROSIS 14 0.0003
427 DECREASED INTEREST 2 0.0003
428 GLUCOSE TOLERANCE IMPAIRED 2 0.0003
429 EYE PAIN 19 0.0003
430 ACCIDENT 4 0.0003
431 WEIGHT INCREASED 75 0.0003
432 SYMPTOM RECURRENCE 2 0.0003
433 WRIST FRACTURE 4 0.0003
434 ANAL INCONTINENCE 3 0.0003
435 GASTROENTERITIS VIRAL 6 0.0003
436 TOOTHACHE 6 0.0003
437 COVID-19 58 0.0003
438 ECONOMIC PROBLEM 5 0.0003
439 BURSITIS 4 0.0003
440 SUICIDAL IDEATION 30 0.0003
441 IRRITABLE BOWEL SYNDROME 7 0.0003
442 ABDOMINAL DISTENSION 34 0.0003
443 ANGER 11 0.0003
444 INTERVERTEBRAL DISC DEGENERATION 3 0.0003
445 PIGMENTATION DISORDER 2 0.0003
446 PRODUCT DISTRIBUTION ISSUE 3 0.0003
447 TENDONITIS 5 0.0003
448 THINKING ABNORMAL 6 0.0003
449 MUSCLE SPASMS 59 0.0003
450 APPLICATION SITE IRRITATION 4 0.0003
451 NASOPHARYNGITIS 59 0.0003
452 FLANK PAIN 3 0.0003
453 SPINAL DISORDER 3 0.0003
454 ABDOMINAL PAIN LOWER 8 0.0003
455 PHOTOPSIA 2 0.0003
456 RED BLOOD CELL COUNT DECREASED 9 0.0003
457 EYE INFLAMMATION 3 0.0003
458 SCIATICA 5 0.0003
459 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
460 BALANCE DISORDER 27 0.0003
461 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 15 0.0003
462 MUSCLE TIGHTNESS 5 0.0003
463 EAR PAIN 6 0.0003
464 DRUG SPECIFIC ANTIBODY PRESENT 2 0.0003
465 BACK DISORDER 5 0.0003
466 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 9 0.0003
467 RESPIRATORY TRACT INFECTION 8 0.0003
468 OSTEOARTHRITIS 13 0.0003
469 VITREOUS FLOATERS 3 0.0003
470 THERAPY CHANGE 3 0.0003
471 SOMNAMBULISM 2 0.0003
472 NECK PAIN 17 0.0003
473 URINARY INCONTINENCE 9 0.0003
474 ORAL CANDIDIASIS 4 0.0003
475 MUSCLE TWITCHING 7 0.0003
476 PRODUCT FORMULATION ISSUE 2 0.0003
477 UPPER RESPIRATORY TRACT INFECTION 14 0.0003
478 UPPER LIMB FRACTURE 6 0.0003
479 SKIN DISORDER 10 0.0003
480 URINARY RETENTION 10 0.0003
481 SPINAL FRACTURE 6 0.0003
482 MALIGNANT MELANOMA 4 0.0003
483 DISTURBANCE IN ATTENTION 16 0.0003
484 POSTOPERATIVE WOUND INFECTION 2 0.0003
485 THROAT TIGHTNESS 8 0.0003
486 EYE IRRITATION 17 0.0003
487 EYELID PTOSIS 3 0.0003
488 TOOTH ABSCESS 3 0.0003
489 SLUGGISHNESS 3 0.0003
490 MOOD ALTERED 8 0.0003
491 MATERNAL EXPOSURE BEFORE PREGNANCY 2 0.0003
492 SCAR 5 0.0003
493 SKIN LESION 8 0.0003
494 ONYCHOCLASIS 2 0.0003
495 TENDERNESS 3 0.0003
496 PETECHIAE 3 0.0003
497 FORMICATION 2 0.0003
498 HUNGER 4 0.0003
499 ORTHOSTATIC HYPOTENSION 5 0.0003
500 NERVOUSNESS 15 0.0003
501 APHONIA 4 0.0003
502 FULL BLOOD COUNT ABNORMAL 3 0.0003
503 PAIN IN JAW 8 0.0003
504 HAND FRACTURE 2 0.0003
505 FLATULENCE 16 0.0003
506 JOINT INJURY 6 0.0003
507 OROPHARYNGEAL PAIN 26 0.0003
508 GALLBLADDER DISORDER 5 0.0003
509 PARALYSIS 4 0.0003
510 ARRHYTHMIA 13 0.0003
511 HEADACHE 172 0.0003
512 LIQUID PRODUCT PHYSICAL ISSUE 2 0.0003
513 IMPAIRED HEALING 9 0.0003
514 TOOTH FRACTURE 3 0.0003
515 BLOOD PRESSURE DIASTOLIC DECREASED 2 0.0003
516 TOOTH DISORDER 6 0.0003
517 EYE SWELLING 10 0.0003
518 SUNBURN 2 0.0003
519 MALNUTRITION 3 0.0003
520 THERAPEUTIC PRODUCT EFFECT DECREASED 12 0.0003
521 BLOOD POTASSIUM DECREASED 8 0.0003
522 GASTRITIS 7 0.0003
523 EYE INFECTION 3 0.0003
524 INTESTINAL OBSTRUCTION 10 0.0003
525 BLOOD SODIUM DECREASED 5 0.0003
526 LACRIMATION INCREASED 8 0.0003
527 IMPAIRED DRIVING ABILITY 3 0.0003
528 PRODUCT AVAILABILITY ISSUE 6 0.0003
529 BLOOD URINE PRESENT 5 0.0003
530 SCAB 3 0.0003
531 INTENTIONAL PRODUCT USE ISSUE 23 0.0003
532 INCREASED APPETITE 5 0.0003
533 NEOPLASM 3 0.0003
534 POST PROCEDURAL COMPLICATION 5 0.0003
535 EMOTIONAL DISORDER 8 0.0003
536 MUSCULOSKELETAL CHEST PAIN 4 0.0003
537 ERUCTATION 5 0.0003
538 DELUSION 4 0.0003
539 INFUSION RELATED REACTION 17 0.0003
540 DYSPHONIA 15 0.0003
541 THERAPY PARTIAL RESPONDER 4 0.0003
542 HAEMORRHOIDS 5 0.0003
543 SURGERY 15 0.0003
544 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
545 KIDNEY INFECTION 5 0.0003
546 ARTERIAL OCCLUSIVE DISEASE 2 0.0003
547 CHEST DISCOMFORT 26 0.0003
548 NASAL DISCOMFORT 2 0.0003
549 RESPIRATORY TRACT CONGESTION 4 0.0003
550 ULCER 4 0.0003
551 FEELING ABNORMAL 60 0.0003
552 BACK PAIN 58 0.0002
553 IRRITABILITY 15 0.0002
554 THROMBOSIS 20 0.0002
555 BLOOD PRESSURE INCREASED 38 0.0002
556 PARAESTHESIA 39 0.0002
557 PANIC ATTACK 9 0.0002
558 FIBROMYALGIA 6 0.0002
559 DRY MOUTH 20 0.0002
560 SMALL INTESTINAL OBSTRUCTION 3 0.0002
561 HERPES ZOSTER 14 0.0002
562 ABNORMAL WEIGHT GAIN 3 0.0002
563 CYST 3 0.0002
564 ARTHRITIS 19 0.0002
565 MUSCLE INJURY 2 0.0002
566 INTENTIONAL PRODUCT MISUSE 21 0.0002
567 CHILLS 28 0.0002
568 PERICARDITIS 4 0.0002
569 UNEVALUABLE EVENT 18 0.0002
570 ACNE 18 0.0002
571 CANDIDA INFECTION 4 0.0002
572 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 8 0.0002
573 TACHYCARDIA 21 0.0002
574 BLOOD CHOLESTEROL INCREASED 11 0.0002
575 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 4 0.0002
576 RETCHING 5 0.0002
577 RESPIRATORY DISORDER 7 0.0002
578 PRODUCT CONTAINER ISSUE 2 0.0002
579 SKIN HYPERPIGMENTATION 2 0.0002
580 PARANOIA 4 0.0002
581 HIATUS HERNIA 3 0.0002
582 HYPERTENSION 49 0.0002
583 HYSTERECTOMY 2 0.0002
584 VERTIGO 14 0.0002
585 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2 0.0002
586 SEDATION 6 0.0002
587 INTERVERTEBRAL DISC PROTRUSION 5 0.0002
588 ANXIETY 65 0.0002
589 BEDRIDDEN 3 0.0002
590 IMMUNE SYSTEM DISORDER 3 0.0002
591 HYPOAESTHESIA 34 0.0002
592 DYSMENORRHOEA 3 0.0002
593 LETHARGY 13 0.0002
594 HAIR TEXTURE ABNORMAL 3 0.0002
595 FOREIGN BODY IN REPRODUCTIVE TRACT 2 0.0002
596 GASTROINTESTINAL INFECTION 2 0.0002
597 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 45 0.0002
598 HEART RATE IRREGULAR 5 0.0002
599 CRYING 8 0.0002
600 CONSTIPATION 48 0.0002
601 FATIGUE 171 0.0002
602 GAIT DISTURBANCE 42 0.0002
603 NEPHROLITHIASIS 10 0.0002
604 RASH 95 0.0002
605 PNEUMONIA BACTERIAL 2 0.0002
606 BRAIN NEOPLASM 2 0.0002
607 CONJUNCTIVITIS 4 0.0002
608 DEMENTIA 6 0.0002
609 MASS 3 0.0002
610 MIDDLE INSOMNIA 4 0.0002
611 DYSPEPSIA 21 0.0002
612 LEUKAEMIA 2 0.0002
613 GASTROOESOPHAGEAL REFLUX DISEASE 17 0.0002
614 THERAPEUTIC RESPONSE SHORTENED 7 0.0002
615 COLITIS 8 0.0002
616 FOOT FRACTURE 4 0.0002
617 PRURITUS 81 0.0002
618 PAIN IN EXTREMITY 62 0.0002
619 PRODUCT PRESCRIBING ERROR 5 0.0002
620 IMPAIRED QUALITY OF LIFE 3 0.0002
621 HYPERTHYROIDISM 3 0.0002
622 HYPERCHOLESTEROLAEMIA 2 0.0002
623 MENTAL IMPAIRMENT 5 0.0002
624 PRESYNCOPE 5 0.0002
625 DYSSTASIA 6 0.0002
626 BONE PAIN 12 0.0002
627 SKIN FISSURES 4 0.0002
628 HAEMATURIA 7 0.0002
629 NASAL CONGESTION 12 0.0002
630 BODY TEMPERATURE DECREASED 2 0.0002
631 RASH PRURITIC 11 0.0002
632 DISORIENTATION 8 0.0002
633 BLADDER DISORDER 2 0.0002
634 IMMUNODEFICIENCY 3 0.0002
635 RHINORRHOEA 13 0.0002
636 OVARIAN CYST 2 0.0002
637 MYALGIA 34 0.0002
638 HEART RATE DECREASED 7 0.0002
639 HALLUCINATION 15 0.0002
640 PRODUCT USE IN UNAPPROVED INDICATION 49 0.0002
641 FEEDING DISORDER 4 0.0002
642 TASTE DISORDER 4 0.0002
643 PSORIATIC ARTHROPATHY 8 0.0002
644 WEIGHT DECREASED 55 0.0002
645 MEMORY IMPAIRMENT 27 0.0002
646 MOTOR DYSFUNCTION 2 0.0002
647 BODY TEMPERATURE INCREASED 4 0.0002
648 THERAPY INTERRUPTED 14 0.0002
649 HIP ARTHROPLASTY 3 0.0002
650 HYPOPHAGIA 5 0.0002
651 INJECTION SITE WARMTH 4 0.0002
652 HYPERHIDROSIS 25 0.0002
653 CONDITION AGGRAVATED 59 0.0002
654 LIMB DISCOMFORT 6 0.0002
655 TEMPERATURE INTOLERANCE 2 0.0002
656 ANKLE FRACTURE 3 0.0002
657 EXPOSURE VIA SKIN CONTACT 5 0.0002
658 BASAL CELL CARCINOMA 3 0.0002
659 SWOLLEN TONGUE 6 0.0002
660 RESTLESSNESS 7 0.0002
661 ROAD TRAFFIC ACCIDENT 8 0.0002
662 DERMATITIS 4 0.0002
663 JOINT STIFFNESS 5 0.0002
664 BLOOD LACTATE DEHYDROGENASE INCREASED 3 0.0002
665 RENAL PAIN 2 0.0002
666 DIZZINESS 94 0.0002
667 DYSGEUSIA 14 0.0002
668 PREMATURE DELIVERY 3 0.0002
669 OBESITY 3 0.0002
670 FLUSHING 19 0.0002
671 HEREDITARY ANGIOEDEMA 2 0.0002
672 DYSPNOEA EXERTIONAL 7 0.0002
673 DECREASED ACTIVITY 2 0.0002
674 URTICARIA 31 0.0002
675 ABDOMINAL DISCOMFORT 31 0.0002
676 CATARACT 11 0.0002
677 DEPRESSION 42 0.0002
678 SLEEP DISORDER 13 0.0002
679 MENTAL DISORDER 8 0.0002
680 PRODUCT DISPENSING ERROR 4 0.0002
681 VISION BLURRED 25 0.0002
682 GASTROINTESTINAL PAIN 2 0.0002
683 ABNORMAL DREAMS 5 0.0002
684 DENTAL CARIES 2 0.0002
685 NERVE INJURY 2 0.0002
686 GASTROINTESTINAL DISORDER 16 0.0002
687 RASH PAPULAR 4 0.0002
688 SNEEZING 4 0.0002
689 THROAT IRRITATION 8 0.0002
690 COUGH 50 0.0002
691 OXYGEN SATURATION DECREASED 10 0.0002
692 FALL 59 0.0002
693 AGITATION 13 0.0002
694 FLUID RETENTION 9 0.0002
695 PRODUCT DOSE OMISSION IN ERROR 5 0.0002
696 APPLICATION SITE PRURITUS 4 0.0002
697 ABDOMINAL PAIN 41 0.0002
698 MYOCARDIAL ISCHAEMIA 2 0.0002
699 THERAPY CESSATION 9 0.0002
700 DELIRIUM 6 0.0002
701 INFECTION 25 0.0002
702 DRY SKIN 23 0.0002
703 MADAROSIS 2 0.0002
704 COGNITIVE DISORDER 8 0.0002
705 SPINAL PAIN 2 0.0002
706 SEXUAL DYSFUNCTION 2 0.0002
707 DEPRESSED MOOD 9 0.0002
708 TREMOR 28 0.0002
709 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 12 0.0002
710 OCULAR HYPERAEMIA 8 0.0002
711 ASTHENIA 63 0.0002
712 HYPERLIPIDAEMIA 2 0.0002
713 NAUSEA 132 0.0002
714 BLOOD PRESSURE FLUCTUATION 4 0.0002
715 CONTUSION 16 0.0002
716 APHASIA 5 0.0002
717 LOCALISED INFECTION 4 0.0002
718 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 3 0.0002
719 LUNG DISORDER 8 0.0002
720 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
721 CARDIOMEGALY 2 0.0002
722 INJECTION SITE MASS 6 0.0002
723 GENERALISED OEDEMA 2 0.0002
724 PHARYNGITIS 2 0.0002
725 HEPATIC STEATOSIS 3 0.0002
726 BACTERIAL INFECTION 3 0.0002
727 INJECTION SITE DISCOLOURATION 2 0.0002
728 PHOTOPHOBIA 3 0.0002
729 ASTHMA 18 0.0002
730 ARTHRALGIA 66 0.0002
731 GLYCOSYLATED HAEMOGLOBIN INCREASED 4 0.0002
732 MUSCLE ATROPHY 2 0.0002
733 NEUROPATHY PERIPHERAL 15 0.0002
734 MUSCULOSKELETAL DISORDER 3 0.0002
735 LOSS OF CONSCIOUSNESS 20 0.0002
736 CHOKING 3 0.0002
737 HAEMORRHAGE 16 0.0002
738 SKIN DISCOLOURATION 7 0.0002
739 HAEMATOCRIT DECREASED 3 0.0002
740 VIRAL INFECTION 5 0.0002
741 PAIN 92 0.0001
742 INJECTION SITE PRURITUS 10 0.0001
743 EYE PRURITUS 5 0.0001
744 PAIN OF SKIN 4 0.0001
745 MUSCULOSKELETAL STIFFNESS 13 0.0001
746 TRANSIENT ISCHAEMIC ATTACK 5 0.0001
747 PRODUCT TASTE ABNORMAL 2 0.0001
748 TREATMENT NONCOMPLIANCE 8 0.0001
749 HYPERSENSITIVITY 27 0.0001
750 VISUAL IMPAIRMENT 18 0.0001
751 SOMNOLENCE 29 0.0001
752 ORAL DISCOMFORT 2 0.0001
753 INFLUENZA 16 0.0001
754 WOUND 4 0.0001
755 KNEE ARTHROPLASTY 3 0.0001
756 MOUTH ULCERATION 3 0.0001
757 DEVICE OCCLUSION 2 0.0001
758 TARDIVE DYSKINESIA 4 0.0001
759 SINUS TACHYCARDIA 2 0.0001
760 MUSCULAR WEAKNESS 16 0.0001
761 CHEST PAIN 26 0.0001
762 IMPAIRED WORK ABILITY 3 0.0001
763 BRONCHOSPASM 2 0.0001
764 INCORRECT PRODUCT ADMINISTRATION DURATION 3 0.0001
765 FAECES DISCOLOURED 3 0.0001
766 DEVICE LEAKAGE 6 0.0001
767 AMNESIA 9 0.0001
768 ANOSMIA 2 0.0001
769 INJECTION SITE HAEMATOMA 2 0.0001
770 NEEDLE ISSUE 4 0.0001
771 INJECTION SITE ERYTHEMA 17 0.0001
772 ERYTHEMA 28 0.0001
773 DYSPNOEA 77 0.0001
774 BLOOD PRESSURE DECREASED 9 0.0001
775 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
776 SKIN HAEMORRHAGE 2 0.0001
777 INFLUENZA LIKE ILLNESS 11 0.0001
778 ADVERSE DRUG REACTION 12 0.0001
779 BONE LOSS 2 0.0001
780 INJECTION SITE REACTION 9 0.0001
781 SKIN EXFOLIATION 11 0.0001
782 PERIPHERAL SWELLING 20 0.0001
783 DRUG INEFFECTIVE 168 0.0001
784 ANAPHYLACTIC REACTION 7 0.0001
785 DYSPHAGIA 12 0.0001
786 ABDOMINAL PAIN UPPER 26 0.0001
787 PNEUMOTHORAX 2 0.0001
788 HALLUCINATION, AUDITORY 2 0.0001
789 SENSORY DISTURBANCE 2 0.0001
790 BLOOD POTASSIUM INCREASED 2 0.0001
791 DEEP VEIN THROMBOSIS 8 0.0001
792 OEDEMA PERIPHERAL 15 0.0001
793 ENCEPHALOPATHY 3 0.0001
794 MULTIPLE FRACTURES 2 0.0001
795 EYE DISORDER 4 0.0001
796 MANIA 2 0.0001
797 OSTEONECROSIS OF JAW 3 0.0001
798 GENERALISED TONIC-CLONIC SEIZURE 2 0.0001
799 PSYCHOMOTOR HYPERACTIVITY 2 0.0001
800 EXPIRED PRODUCT ADMINISTERED 4 0.0001
801 AGEUSIA 3 0.0001
802 LIP SWELLING 4 0.0001
803 COAGULOPATHY 2 0.0001
804 DEHYDRATION 16 0.0001
805 GAIT INABILITY 4 0.0001
806 BLOOD UREA INCREASED 2 0.0001
807 ADVERSE EVENT 11 0.0001
808 PRODUCT COMPLAINT 3 0.0001
809 WHEEZING 7 0.0001
810 DIARRHOEA 76 0.0001
811 ERECTILE DYSFUNCTION 3 0.0001
812 RECTAL HAEMORRHAGE 5 0.0001
813 INFLAMMATION 6 0.0001
814 MUSCULOSKELETAL DISCOMFORT 2 0.0001
815 HAEMATOMA 3 0.0001
816 ECZEMA 6 0.0001
817 RASH MACULAR 4 0.0001
818 DEVICE USE ISSUE 2 0.0001
819 NEUROTOXICITY 2 0.0001
820 AMENORRHOEA 2 0.0001
821 MALAISE 50 0.0001
822 HYPOXIA 4 0.0001
823 LYMPHOCYTE COUNT DECREASED 2 0.0001
824 ATRIAL FIBRILLATION 11 0.0001
825 DRUG ERUPTION 2 0.0001
826 COLITIS ULCERATIVE 5 0.0001
827 PRODUCT USE ISSUE 21 0.0001
828 CEREBRAL HAEMORRHAGE 4 0.0001
829 BLOOD BILIRUBIN INCREASED 3 0.0001
830 WHITE BLOOD CELL COUNT DECREASED 12 0.0001
831 COMPLICATION OF DEVICE REMOVAL 2 0.0001
832 LEUKOCYTOSIS 2 0.0001
833 PNEUMONITIS 3 0.0001
834 BONE DISORDER 2 0.0001
835 SKIN IRRITATION 5 0.0001
836 HAEMATOCHEZIA 6 0.0001
837 DIVERTICULITIS 3 0.0001
838 DRUG ABUSE 9 0.0001
839 ARTHROPATHY 6 0.0001
840 JOINT SWELLING 13 0.0001
841 HAEMOPTYSIS 3 0.0001
842 BLISTER 6 0.0001
843 GASTRIC ULCER 2 0.0001
844 PULMONARY EMBOLISM 10 0.0001
845 CONFUSIONAL STATE 17 0.0001
846 DISEASE RECURRENCE 5 0.0001
847 RASH ERYTHEMATOUS 5 0.0001
848 INJECTION SITE SWELLING 8 0.0001
849 WHITE BLOOD CELL COUNT INCREASED 4 0.0001
850 PRODUCT SUBSTITUTION ISSUE 6 0.0001
851 BLOOD GLUCOSE DECREASED 5 0.0001
852 GLAUCOMA 2 0.0001
853 HERNIA 2 0.0001
854 PNEUMONIA 33 0.0001
855 DEPRESSED LEVEL OF CONSCIOUSNESS 4 0.0001
856 DRUG INTERACTION 16 0.0001
857 INJECTION SITE BRUISING 8 0.0001
858 PRESCRIBED UNDERDOSE 2 0.0001
859 VOMITING 47 0.0001
860 ILL-DEFINED DISORDER 6 0.0001
861 EXTRA DOSE ADMINISTERED 4 0.0001
862 DYSKINESIA 4 0.0001
863 EPILEPSY 3 0.0001
864 INJECTION SITE RASH 3 0.0001
865 MOBILITY DECREASED 7 0.0001
866 RIB FRACTURE 2 0.0001
867 BREAST CANCER 9 0.0001
868 EXPOSURE DURING PREGNANCY 6 0.0001
869 NERVOUS SYSTEM DISORDER 3 0.0001
870 BONE DENSITY DECREASED 3 0.0001
871 SPEECH DISORDER 5 0.0001
872 DERMATITIS ATOPIC 5 0.0001
873 HIP FRACTURE 3 0.0001
874 SKIN CANCER 2 0.0001
875 PRURITUS GENERALISED 2 0.0001
876 OEDEMA 5 0.0001
877 BLOOD CREATININE INCREASED 6 0.0001
878 PRODUCT PRESCRIBING ISSUE 2 0.0001
879 STAPHYLOCOCCAL INFECTION 3 0.0001
880 LIVER DISORDER 4 0.0001
881 NEOPLASM MALIGNANT 6 0.0001
882 PYREXIA 31 0.0001
883 GLOSSODYNIA 2 0.0001
884 PULMONARY OEDEMA 4 0.0001
885 ORAL PAIN 2 0.0001
886 THERAPY NON-RESPONDER 4 0.0001
887 HYPONATRAEMIA 5 0.0001
888 HEPATIC ENZYME INCREASED 6 0.0001
889 CONVULSION 5 0.0001
890 ACCIDENTAL EXPOSURE TO PRODUCT 9 0.0001
891 SEIZURE 10 0.0001
892 PERICARDIAL EFFUSION 2 0.0001
893 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 4 0.0001
894 INJURY 6 0.0001
895 ANAEMIA 16 0.0001
896 RENAL IMPAIRMENT 7 0.0001
897 WRONG TECHNIQUE IN DRUG USAGE PROCESS 3 0.0001
898 LIVER INJURY 2 0.0001
899 HYPOTENSION 16 0.0001
900 DYSARTHRIA 3 0.0001
901 HAEMATEMESIS 2 0.0001
902 MATERNAL EXPOSURE DURING PREGNANCY 7 0.0001
903 INJECTION SITE PAIN 24 0.0001
904 HAEMOGLOBIN DECREASED 8 0.0001
905 SKIN ULCER 2 0.0001
906 DIPLOPIA 2 0.0001
907 INCORRECT DOSE ADMINISTERED BY DEVICE 2 0.0001
908 ANHEDONIA 2 0.0001
909 CARDIAC FAILURE 6 0.0001
910 INCORRECT DOSE ADMINISTERED 17 0.0001
911 EMOTIONAL DISTRESS 9 0.0001
912 FREQUENT BOWEL MOVEMENTS 2 0.0001
913 DEVICE BREAKAGE 3 0.0001
914 PRODUCT QUALITY ISSUE 10 0.0001
915 BLINDNESS 3 0.0001
916 PALLOR 2 0.0001
917 PROCEDURAL PAIN 2 0.0001
918 MENTAL STATUS CHANGES 2 0.0001
919 SKIN BURNING SENSATION 5 0.0001
920 DECREASED APPETITE 16 0.0001
921 PRODUCT STORAGE ERROR 6 0.0001
922 ACUTE MYOCARDIAL INFARCTION 2 0.0001
923 RENAL FAILURE 9 0.0001
924 LABORATORY TEST ABNORMAL 2 0.0001
925 PREMATURE BABY 2 0.0001
926 HEPATIC FAILURE 2 0.0001
927 CHRONIC KIDNEY DISEASE 5 0.0001
928 DRUG ADMINISTRATION ERROR 2 0.0001
929 ALANINE AMINOTRANSFERASE INCREASED 4 0.0001
930 RENAL DISORDER 3 0.0001
931 DRUG-INDUCED LIVER INJURY 2 0.0001
932 BLOOD GLUCOSE INCREASED 12 0.0001
933 INTENTIONAL OVERDOSE 4 0.0001
934 DRUG INTOLERANCE 6 0.0001
935 INTERSTITIAL LUNG DISEASE 3 0.0001
936 CHOLELITHIASIS 2 0.0001
937 OSTEONECROSIS 2 0.0001
938 DEVICE DIFFICULT TO USE 4 0.0001
939 LEUKOPENIA 3 0.0001
940 GASTRIC DISORDER 2 0.0001
941 NIGHTMARE 2 0.0001
942 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
943 DRUG WITHDRAWAL SYNDROME 5 0.0001
944 ASPARTATE AMINOTRANSFERASE INCREASED 3 0.0001
945 PLATELET COUNT DECREASED 6 0.0001
946 DEVICE ISSUE 5 0.0001
947 DRUG EFFECT DECREASED 3 0.0001
948 OVERDOSE 12 0.0001
949 NO ADVERSE EVENT 10 0.0001
950 HYPERGLYCAEMIA 2 0.0001
951 SEPSIS 6 0.0001
952 PSORIASIS 7 0.0001
953 EPISTAXIS 4 0.0001
954 CARDIAC DISORDER 5 0.0001
955 RHEUMATOID ARTHRITIS 6 0.0001
956 DIABETES MELLITUS 4 0.0001
957 ABORTION SPONTANEOUS 2 0.0000
958 THERAPEUTIC RESPONSE DECREASED 3 0.0000
959 STOMATITIS 3 0.0000
960 PLEURAL EFFUSION 3 0.0000
961 ACUTE KIDNEY INJURY 7 0.0000
962 ANGIOEDEMA 2 0.0000
963 MULTIPLE SCLEROSIS RELAPSE 3 0.0000
964 HYPOKALAEMIA 2 0.0000
965 GENERAL PHYSICAL HEALTH DETERIORATION 5 0.0000
966 CEREBROVASCULAR ACCIDENT 7 0.0000
967 RESPIRATORY FAILURE 3 0.0000
968 SYNCOPE 4 0.0000
969 AGGRESSION 2 0.0000
970 HOSPITALISATION 6 0.0000
971 DRUG DOSE OMISSION BY DEVICE 3 0.0000
972 MUSCULOSKELETAL PAIN 2 0.0000
973 PANCREATITIS 2 0.0000
974 INJECTION SITE HAEMORRHAGE 3 0.0000
975 FOETAL EXPOSURE DURING PREGNANCY 3 0.0000
976 TREATMENT FAILURE 3 0.0000
977 MEDICATION ERROR 2 0.0000
978 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
979 THROMBOCYTOPENIA 4 0.0000
980 DISEASE PROGRESSION 4 0.0000
981 NEUTROPENIA 4 0.0000
982 MYOCARDIAL INFARCTION 5 0.0000
983 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
984 DEATH 24 0.0000
985 CARDIAC FAILURE CONGESTIVE 2 0.0000
986 DRUG DEPENDENCE 3 0.0000
987 DRUG DOSE OMISSION 2 0.0000